Genelux CorporationGNLXNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+1040.9%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+1040.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1485.1x
Strong expansion
Streak
4 yr
Consecutive growthElevated
PeriodValueYoY Change
202520261.21+118.4%
20249277.96+360.8%
20232013.26+14656.4%
202213.64-
20210.00-
20200.00-
20190.00-